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Abstract
Background: Lymphatic endothelial cell (LEC) immunohistochemical markers have
identified intestinal lymphatic vasculature abnormalities in humans with inflammatory
bowel disease, but have not been used to evaluate intestinal lymphatic vasculature in
a group of dogs with chronic inflammatory enteropathy (CIE).
Objectives: To utilize LEC markers to identify and measure intestinal lymphatic vas-
culature in endoscopic biopsy samples of CIE dogs. To evaluate whether measured
lymphatic vasculature variables correlate with serum albumin concentrations.
Animals: Twenty-four dogs with CIE; n = 13, serum albumin concentration <2.5 g/dL
(CIE-protein-losing enteropathy [PLE]), n = 11, serum albumin concentration ≥2.5 g/dL
(CIE-N).
Methods: Prospective study. Lymphatic endothelial cell immunolabeling with Prox-1
and LYVE-1 performed on endoscopic biopsy samples from 24 dogs with CIE. Duo-
denal and ileal villous lacteal width (VLW) and proprial mucosal lacteal width (MLW)
were determined for each case and analyzed for correlation with serum albumin con-
centration. Lacteal dilatation scores using routine H&E histopathology were assessed
for correlation with immunohistochemistry (IHC)-calculated VLW and MLW.
Results: Lower serum albumin concentrations were correlated with increased VLW
(rho = −.4644; P = .02) and MLW (rho = −.6514; P < .001) in the ileum. Lymphatic
endothelial cell IHC identified presumptive proprial mucosal lymphangiectasia in
some dogs that was not recognized with routine H&E staining. Lacteal dilatation
scores were correlated with VLW in duodenum (rho = .4634; P = .02) and ileum
(rho = .5292; P = .008), but did not correlate with MLW.
Abbreviations: CCECAI, canine chronic enteropathy clinical activity index; CD, Crohn's disease; CIE, chronic inflammatory enteropathy; CIE-N, chronic inflammatory enteropathy with serum
albumin concentrations ≥2.5 g/dL; CIE-PLE, chronic inflammatory enteropathy with protein-losing enteropathy; IHC, immunohistochemistry; IL, intestinal lymphangiectasia; LD, lacteal dilatation;
LEC, lymphatic endothelial cell; LYVE-1, lymphatic vascular endothelial hyaluronic acid receptor; MLW, mucosal lacteal width; PLE, protein-losing enteropathy; Prox-1, human prospero
homeobox; VLW, villus lacteal width.
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Conclusions and Clinical Importance: Lymphatic endothelial cell immunolabeling
identified presumptive proprial mucosal lymphangiectasia in CIE dogs, particularly in
the ileum of hypoalbuminemic dogs. Routine evaluation of villous lacteals likely
underestimates abnormalities of the lymphatic vasculature in dogs with CIE.
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1 | INTRODUCTION
Chronic inflammatory enteropathy (CIE) refers to conditions of the intes-
tinal tract that are characterized by the presence of gastrointestinal signs
of at least 3 weeks' duration, histologic evidence of intestinal inflamma-
tion, and the exclusion of neoplastic, infectious, and extra-gastrointestinal
causes of gastrointestinal signs.1-3 Intestinal lymphangiectasia (IL) is a
disorder of dilated lymphatic vasculature at any level of the intestinal
lymphatic system. Although it can be a primary condition, it also can
occur secondary to a variety of other intestinal disorders, including CIE.
When it occurs secondary to CIE, it is presumably a result of increased
lymphatic pressure associated with inflammatory infiltrates in the intes-
tine, and may result in hypoalbuminemia, or protein-losing enteropathy
(PLE), because of direct loss of protein-rich lymph, lymphatic dysfunc-
tion, or both.4-6
Several recent studies have found a relationship between serum
albumin concentrations and IL in cases of idiopathic CIE in the dog,
however lymphatic abnormalities have been inconsistently reported.7-9
Lymphangiectasia can be underappreciated on routine histopathologic
examination of the intestine, because it can have a segmental distribu-
tion and, in some cases, be confined to deeper layers of the intestine
that may not be sampled endoscopically.5,6 Lymphatic abnormalities
can be similarly confined to the deeper layers of the intestine in cases
of Crohn's disease (CD),10-12 a type of inflammatory bowel disease in
humans characterized by idiopathic inflammation that can be localized
to the ileum or found diffusely throughout the small intestine.13 In
some cases of CD, dilated lymphatics are not identified in the superfi-
cial mucosa, but rather found in the deeper mucosa, submucosa, and
muscularis layers of the intestine, as well as in the mesentery.14,15 In
humans with CD, immunolabeling with lymphatic endothelial cell (LEC)-
specific markers is superior to standard microscopy for identifying
abnormalities of the lymphatic vasculature, including lymphangiectasia,
and obstructed lymphatics.15
Lymphatic endothelial cells are derived from venous progenitor
cells and express various antigens that distinguish them from blood ves-
sel endothelial cells.16 Lymphatic endothelial cell markers are numerous
and include human prospero homeobox (Prox-1), a nuclear transcription
factor,17 and lymphatic vascular endothelial hyaluronic acid receptor
(LYVE-1).18 Prox-1 and LYVE-1 immunolabeling previously has been
used to differentiate types of angiosarcomas in the dog,19 but to our
knowledge has not been used to evaluate the intestinal lymphatic vas-
culature in dogs with CIE.
Our objective was to utilize the LEC markers Prox-1 and LYVE-1 to
identify and evaluate the intestinal lymphatic vasculature in endoscopic
biopsy samples of dogs with CIE, and to determine whether abnormali-
ties associated with the lymphatic vasculature were related to serum
albumin concentrations in dogs with idiopathic CIE.
2 | MATERIALS AND METHODS
2.1 | Study population
Client-owned dogs presented to the Colorado State University Veteri-
nary Teaching Hospital for evaluation of chronic gastrointestinal signs
(eg, decreased appetite, vomiting, diarrhea, and weight loss) of >3 weeks'
duration were recruited for participation in the study. To be eligible
for inclusion, dogs were required to have had routine fecal screening
with no parasites detected, no evidence of clinically relevant non-
gastrointestinal illness, as assessed by routine hematology and serum
biochemical profile, and a histopathologic diagnosis of inflammatory
enteritis for which no distinct cause could be identified. Dogs had to
have had duodenal and ileal biopsies performed. Dogs with histopath-
ologic evidence of intestinal neoplasia were excluded. To be eligible
for the study, exclusion of exocrine pancreatic insufficiency as a cause
of clinical signs with a fasted serum canine trypsin-like immunoreactiv-
ity concentration >5.0 ng/mL was required. Hypoalbuminemic dogs
(serum albumin concentration <2.5 g/dL) also were required to have
no clinically relevant proteinuria (negative urine dipstick test result or
urine protein:creatinine ratio <0.5) and no evidence of clinically rele-
vant hepatic disease based on normal fasted and postprandial bile acid
concentrations or normal synthetic liver function and enzyme activity
on routine serum biochemistry profile.
Recorded data included age, breed, sex, weight, duration of illness,
clinicopathological data, and results of any diagnostic imaging per-
formed. Additionally, at the time of enrollment, owners were asked to
score appetite, activity level, vomiting, fecal consistency, fecal fre-
quency, weight loss, and pruritus for each dog. After the results of the
serum biochemical profile (serum albumin concentration) and abdomi-
nal ultrasound examination (peritoneal effusion), and using the owner's
score, a canine chronic enteropathy clinical activity index (CCECAI)1
was calculated for each dog. The Clinical Review Board at Colorado
State University approved all procedures and written consent was
obtained from the owners of each of the study participants.
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2.2 | Histopathologic evaluation
Twelve duodenal and 5 ileal biopsy samples were obtained from each
dog for histopathologic evaluation. Histopathologic evaluation of endo-
scopically obtained intestinal tissue from CIE dogs was performed by a
board-certified veterinary pathologist (S.L.P.) and pathologist-in-training
(A.S.-B.) blinded to clinical data and clinicopathologic information. Biopsy
samples were assessed as adequate for evaluation, and both patholo-
gists evaluated duodenal and ileal tissues and reached a consensus for
the presence and severity of morphologic criteria (villous stunting, epi-
thelial injury, crypt distension, lacteal dilatation [LD], and mucosal fibro-
sis) and inflammatory criteria (intraepithelial lymphocytes, lamina propria
eosinophils, lamina propria lymphocytes or plasma cells, and lamina
propria neutrophils) based on World Small Animal Veterinary Associa-
tion (WSAVA) guidelines.20 For the severity of each change, the follow-
ing scores were applied based on established criteria: 0 = normal,
1 = mild, 2 = moderate, and 3 = marked. Scores for LD were based on
the most severely affected villus in each case. If the lacteal occupied
0%-25% of the villus width, a score of 0 was given, 25%-50% was a
score of 1, 50%-75% was a score of 2, and >75% of the width of the vil-
lus resulted in a score of 3.
2.3 | Immunohistochemistry
All immunohistochemical (IHC) labeling was performed using a Leica
Bond III immunostainer (Leica Biosystems Inc, California, Illinois).
Formalin-fixed paraffin-embedded tissues were sectioned at 5 μm and
mounted on positively charged slides for IHC. Dewaxing and epitope
retrieval were performed using the Bond III instrument. Epitope
retrieval was performed using the ER1 solution (Leica Biosystems Inc),
a pH 6.0 citrate buffer. Antibodies against Prox-1 (rabbit polyclonal;
Angiobio [Delmar, California]) and LYVE-1 (rabbit polyclonal; Abcam
[Cambridge, Massachusetts]) were diluted 1:100 in PowerVision IHC
Super Block (Leica) and incubated on tissue sections for 20 minutes.
All wash steps were performed in triplicate using Leica Bond wash
buffer. Tissue sections then were incubated for 20 minutes with goat
secondary antibody at 1:200 dilution and alkaline phosphatase poly-
mer. The Leica Fast Red chromogenic substrate for alkaline phospha-
tase was used to detect specific immunoreactivity of each antibody.
Upon completion of immunolabeling, samples were counterstained
with hematoxylin. Isotype-matched irrelevant primary antibodies were
used as negative controls.
2.4 | Immunohistochemical evaluation
The Prox-1 and LYVE-1 IHC slides as well as negative control slides were
digitally scanned using Philips Ultra Fast Scanner slide (Philips IntelliSite
Pathology Solution, Philips Electronics, Amsterdam, the Netherlands) and
analyzed with the use of Philips Image Management System viewer (ver-
sion 2.4.1.2; Phillips IntelliSite Pathology Solution, Phillips Electronics) by
a single evaluator (S.W.), who was blinded to the case data. To be coun-
ted or measured as a lymphatic vessel, a visible lumen was required in
addition to immunolabeling with the LEC markers. Lymphatic vessels
were measured using LYVE-1 immunolabeling. The Prox-1 slides subse-
quently were evaluated to verify the structures as lymphatic vessels.
On 4×, 10 well-oriented villi associated with cryptal tissue and dis-
persed throughout the slide were selected for measurement of villous
lymphatic vessel width (VLW). Lacteal width (μm) was taken as the dis-
tance from 1 side of the lacteal to the other, measured perpendicular to
the midline of the lacteal. Next, well-oriented areas of the propria
mucosa were evaluated at 4× for immunolabeling. In 10 distinct 20×
fields in the propria mucosa, lymphatic vessels were identified and lac-
teal width (μm) was measured perpendicular to the midline of the lac-
teal (mucosal lymphatic vessel width [MLW]). If no lacteals were
identified in the field, the next field was examined. No more than 2 lac-
teals were measured per 20× field. If >2 lacteals were identified in the
field, all visible lacteals were measured, and the widest and most nar-
row lacteal of the group were used in the analysis. In addition, the
viewing trail feature was used to ensure that all areas of the slide were
assessed. For both VLW and MLW, the mean of the 10 measurements
was recorded for each tissue in each case. In 2/24 cases, only 5 defini-
tively measurable mucosal lymphatics could be identified, and therefore
those cases had MLW scores calculated as the mean of the 5 measure-
ments, rather than 10.
2.5 | Statistical analysis
Descriptive statistics were calculated for age, sex, weight, duration of
illness, CCECAI scores, and histopathological scores. The distribution
of data for statistical analysis was assessed by the Shapiro-Wilk test.
Data were not normally distributed. Spearman (rank-based) correla-
tion was used to evaluate relationships between the lymphatic vari-
ables and serum albumin concentration in each section of intestine.
Spearman (rank-based) correlation also was performed to assess the
relationship between the routine LD score as assessed by the blinded
pathologists based on WSAVA guidelines and the VLW and MLW in
each section of the intestine. For Spearman, a statistically significant
correlation score of (+/−) 0.3-0.5 was considered a weak correlation,
(+/−) 0.5-0.7 a moderate correlation, and (+/−) 0.7-1.0 a strong corre-
lation.21 All statistical analysis was performed using GraphPad Prism
scientific statistic software (Graph Pad Prism, GraphPad Software, Inc,
San Diego, California). Statistical significance for all statistical compari-
sons was set at P < .05.
3 | RESULTS
Thirty dogs were screened for inclusion in the study. All dogs were
fasted for a minimum of 24 hours before endoscopic examination and
biopsies. After routine histopathologic evaluation, 1 dog was diagnosed
with intestinal lymphoma and therefore was excluded from the study.
Ileal biopsy samples were not obtained in 2 dogs, which prompted
exclusion from the study. In 3 additional cases, the quality of the endo-
scopic biopsy samples was considered inadequate for IHC evaluation of
LEC markers because of either the presence of only villus tips, or inabil-
ity to accurately examine the lymphatic vasculature because of tissue
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orientation. Therefore, 24 clinical cases were included in the final data
analysis. Twenty-two dogs had a basal serum cortisol concentration
>2 μg/mL or normal response to ACTH, ruling out hypoadrenocorticism
as a cause of their clinical signs. All dogs had routine abdominal ultraso-
nography performed by or under the supervision of a board-certified
veterinary radiologist to evaluate for extra-intestinal disease or extra-
luminal intestinal masses before endoscopic examination.
Of the 24 cases, 13 dogs had serum albumin concentration
<2.5 g/dL, which was defined as chronic inflammatory enteropathy
with PLE (CIE-PLE), and 11 dogs had serum albumin concentration
≥2.5 g/dL (CIE-N). Breeds with CIE-PLE included Bernese Mountain
Dog (2), Labrador Retriever (2), mixed breed dog (2), and 1 each of the
following: Australian Shepherd, English Bulldog, Great Pyrenees, Pem-
broke Welsh Corgi, Pug, Rottweiler, and Yorkshire Terrier. Breeds
with CIE-N included mixed breed dog (3), and 1 each of Australian
Terrier, Bernese Mountain Dog, Brittany Spaniel, Cavalier King
Charles Spaniel, German Shepherd dog, German Shorthaired Pointer,
Labrador Retriever, and Siberian Husky. Dogs with CIE-PLE con-
sisted of 7 neutered males and 5 spayed females, and dogs with
CIE-N consisted of 8 neutered males and 3 spayed females. Addi-
tional descriptive statistics of interest are presented in Table 1. Age
and sex were not different between dogs with CIE-PLE and dogs
with CIE-N.
The Prox-1 and LYVE-1 immunolabeling of lymphatics from a non-
study dog with a histopathologic diagnosis of marked lymphangiectasia
in the duodenum and ileum was used as a positive control. Human
prospero homeobox has been reported to be variably expressed in
enteroendocrine epithelial cells in the crypts.22 In our cases, Prox-1
labeling was visible in some individual crypt epithelial cells but was eas-
ily differentiated from lymphatic vessel endothelial labeling. Although
LYVE-1 is expressed by some macrophages in the intestine,23 this
staining was easily distinguishable from lymphatic vessel endothelial
labeling. Lymphatic endothelial cell labeling was not observed on any of
the negative control slides. Examples of immunolabeled villus lym-
phatics are shown in Figure 1. Examples of immunolabeled proprial
mucosal lymphatics are shown in Figure 2. Villus lacteal width in the
ileum was weakly negatively (rho = −.4644) correlated with serum albu-
min concentration (P = .02). Proprial MLW in the ileum was moderately
negatively (rho = −.6514) correlated with serum albumin concentration
(P < .001).21 Summary statistics and correlation data for lymphatic vari-
ables with serum albumin concentration are presented in Table 2.
Routine H&E LD scores as determined by blinded board-certified
pathologist and pathologist-in-training were assessed for correlation
to the width of the villus and proprial mucosal lymphatics (VLW and
MLW, respectively) as determined by IHC for each tissue section.
Duodenal LD was weakly positively correlated with duodenal VLW
(rho = .4634; P = .02) but not correlated with duodenal MLW
(rho = .2767; P = .19). Ileal LD was moderately positively correlated
with ileal VLW (rho = 5292; P = .008) but not correlated with ileal
MLW (rho = .3889; P = .06).
4 | DISCUSSION
We utilized LEC-specific markers to evaluate the intestinal lymphatic
vasculature in dogs with CIE with and without PLE, as defined by serum
albumin concentration <2.5 g/dL. Lymphatic endothelial cell IHC was
successful in labeling the lymphatic vasculature in dogs with CIE, and
identified apparently dilated lymphatics in the proprial mucosa that
were not identified as lymphatics by routine H&E assessment for
lymphangiectasia. In addition, in our 24 dogs with CIE, serum albumin
concentrations were negatively correlated with villus and MLW in the
ileum. For both the duodenum and the ileum, average VLW as deter-
mined by use of LEC IHC was correlated with LD scores as traditionally
assessed using routine H&E staining. Proprial MLW as determined by
the use of IHC was not correlated with LD scores as traditionally
assessed by routine H&E staining in either section of intestine.
The most striking finding of our study was the presence of apparent
proprial mucosal lymphangiectasia in the intestine of dogs with CIE, in
particular in the ileum of several dogs with CE and serum albumin con-
centrations <2.5 g/dL. In some of these dogs with apparently dilated
proprial mucosal lymphatics, villus lymphatics were not concurrently
dilated and these dogs had not been diagnosed with lymphangiectasia
on routine histopathologic examination. The appearance of the dis-
tended proprial mucosal lymphatics in the ileum of these dogs may be
similar to what has been identified in humans with CD,15 an idiopathic
TABLE 1 Selected descriptive statistics for dogs with chronic
inflammatory enteropathy with (CIE-PLE) and without (CIE-N)
protein-losing enteropathy
Variable
CIE-PLE (n = 13)
median (range)
CIE-N (n = 11)
median (range)
Age 7 (1-10) 4 (1-12)
Body weight (kg) 24 (5-42) 21 (6-43)
CCECAI 11 (5-19) 8 (4-11)
Duration of illness (mo) 3 (1-12) 6 (2-24)
Serum albumin concentration (g/dL) 1.7 (0.9-2.4) 3.3 (2.6-3.9)
Duodenal histologic LD score 1 (0-2) 0 (0-1)
Ileal histologic LD score 0 (0-2) 0 (0-2)
Duodenal mucosal scorea 6 (2-10) 2 (0-9)
Duodenal inflammatory scoreb 5 (2-8) 3 (1-8)
Duodenal total WSAVA score 11 (5-18) 5 (1-13)
Ileal mucosal scorea 4 (0-8) 0 (0-4)
Ileal inflammatory scoreb 3 (0-6) 2 (1-7)
Ileal total WSAVA score 7 (0-14) 2 (1-11)
Notes: LD, mucosal, and inflammatory histologic scores reported in this
table were obtained by blinded evaluation of H&E samples.
Abbreviations: CIE-N, chronic inflammatory enteropathy with serum
albumin concentration ≥2.5 g/dL; CIE-PLE, chronic inflammatory
enteropathy with protein-losing enteropathy (serum albumin <2.5 g/dL);
LD: lacteal dilatation; WSAVA: World Small Animal Veterinary Association.
aTotal score for villus stunting, epithelial injury, crypt distension, lacteal
dilatation, and mucosal fibrosis.
bTotal score for intraepithelial lymphocytes, lamina propria
lymphocytes/plasma cells, lamina propria eosinophils, and lamina propria
neutrophils.
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F IGURE 1 Immunolabeled villous lymphatics of dogs with chronic inflammatory enteropathy (CIE). A, Duodenal villi from dog with CE and
serum albumin concentration of 1.7 g/dL and central villous lymphatic dilation (arrow; lacteal dilation score = 2); human prospero homeobox
immunohistochemistry (IHC). Severe lamina propria lymphoplasmacytic inflammation is also visible. B, Ileal villi from dog with CIE, serum albumin
concentration 1.9 g/dL, and central villous lymphatic dilation (arrow; lacteal dilation score = 2). Cytoplasmic immunoreactivity of lymphatic
endothelial cells shown with lymphatic vascular endothelial hyaluronic acid receptor IHC. Apparent proprial mucosal lymphangiectasia can also be
seen (arrows)
F IGURE 2 Immunolabeled
proprial mucosal lymphatics of
dogs with CIE-PLE (A-D).
Apparent proprial mucosal
lymphangiectasia (arrows) in the
ileum of a dog with CE and
serum albumin concentration
1.5 g/dL at 4× (A) and 20×
(B) power; human prospero
homeobox immunohistochemistry
(IHC). Apparent proprial mucosal
lymphangiectasia (arrowheads and
arrows) in the duodenum of a dog
with serum albumin concentration
1.6 g/dL at 4× (C) and 20×
(D) power; lymphatic vascular
endothelial hyaluronic acid
receptor IHC
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chronic inflammatory intestinal disease most commonly found in the
ileum.13 In humans with CD, lymphangiectasia also has been identified
in the submucosa, muscularis propria and subserosa.14,15,24 Therefore,
it is possible that full thickness intestinal biopsy samples with LEC
immunolabeling may identify more abnormalities in the lymphatic vas-
culature of dogs with CIE than are currently seen in endoscopic biopsy
samples.
Presumptive proprial mucosal lymphangiectasia also was identified
in the duodenum of some dogs with CIE, including in 2 dogs with
serum albumin concentrations ≥2.5 g/dL. Proprial MLW in the duode-
num was not significantly correlated with serum albumin concentra-
tion. It is possible that with an increased sample size, a statistical
difference may have been detected. A previous study comparing his-
tologic findings in the duodenum versus ileum in a group of dogs with
chronic small intestinal enteropathies found hypoalbuminemia to be
correlated with ileal LD, but not with duodenal LD.25 The albumin cor-
relation results of our study also suggest that lymphatic abnormalities
can differ among sections of the intestine, lending additional support
to the recommendation to always obtain ileal samples in the diagnos-
tic evaluation of dogs with CIE.
In many cases, it is unknown whether lymphatic abnormalities are
a cause or consequence of intestinal disease. Regardless, they likely
represent an important component of the disease process. In addition
to their role in the transport of intestinal immune and inflammatory
cells, the lymphatic vasculature is responsible for regulation of the
pressure of interstitial fluid in tissues, and transport of excess fluid
back to the circulation. Furthermore, lymphatic vessels are the main
route of absorption of fat, cholesterol, fat-soluble vitamins, and gas-
trointestinal hormones.24,26 Obstruction or dysfunction of the lym-
phatic vasculature or both should have important consequences, and
the recognition of lymphatic abnormalities is likely important to the
management of dogs with CIE. Although response to treatment and
outcomes were not evaluated in our study, follow-up information was
available for several dogs. Six dogs in the study had an average ileal
mucosal lymphatic width >30 μm, all of which had serum albumin con-
centrations <2.5 g/dL. Blinded ileal LD scores were 0 in 4/6 of these
dogs. Of these dogs, 3 were euthanized as a consequence of their dis-
ease, 1 was euthanized because of unrelated disease, and 2 were alive
at the time of publication. Of the 3 dogs that were euthanized because
of their disease, 2 received traditional treatments including commercial
gastrointestinal diets and glucocorticoids for >2 weeks after their diag-
nosis with no clinically relevant improvement noted. The third dog that
was euthanized initially was glucocorticoid-responsive but then relapsed
when glucocorticoids were tapered and the owner chose not to pursue
further treatment. The other 3 dogs had persistent clinical signs despite
treatment with glucocorticoids, immunosuppressive drugs, vitamin sup-
plementation, supportive care, and commercially available hydrolyzed
and low-fat diets. All 3 of these dogs ultimately had an apparent clinical
response once switched to a veterinary nutritionist-formulated home-
cooked diet, formulated to be lower in fat (10%-15% by metabolizable
energy) than the commercially available diets. Two of those dogs were
alive at the time of publication; the third was euthanized because of
splenic hemangiosarcoma 12 months after response to the home-
cooked diet. Although anecdotal, and only a small number of cases,
this population of dogs may represent a subset of dogs with CIE
that have important abnormalities of their lymphatic vasculature
that require the administration of a diet that is lower in fat than
what is commercially available.
Our study had some limitations. First, biopsy samples from healthy
control dogs were not available, and we cannot accurately determine
normal lymphatic width in the propria mucosa of the intestine. Further
studies of the lymphatic vasculature in dogs with CIE ideally should
include evaluation of samples from healthy control dogs. In addition,
although effort was made to standardize evaluation of the intestinal lym-
phatic vasculature, the sectioning of intestinal tissue, in particular endo-
scopically obtained biopsy samples, cannot be entirely uniform. It is
possible that in some cases the lymphatics were less or more visible
because of the angle of sectioning, and this may have affected the
results. In 2 cases (1 ileal sample from a hypoalbuminemic dog and 1 duo-
denal sample from a normoalbuminemic dog), only 5 measurable mucosal
lymphatics could be definitively identified, compared to 10 in all other
cases, which may have affected the results. Despite the use of a team of
TABLE 2 Intestinal villous and mucosal lymphatic scores for dogs with chronic inflammatory enteropathy with (CIE-PLE) and without (CIE-N)
protein-losing enteropathy
Variable Group Median IQR Min Max
Spearman's
Correlation Scorea P-value*
Duodenal VLW (μm) CIE-PLE
CIE-N
34.6
24.9
20.5
14.9
15
16.4
53.9
63.4
−.2533 .23
Duodenal MLW (μm) CIE-PLE
CIE-N
21.8
11.6
16.9
8.2
9.6
7.1
41.5
39.5
−.3777 .07
Ileal VLW (μm) CIE-PLE
CIE-N
22.9
15.3
24.1
6
11
10.9
51.2
39.8
−.4644 .02
Ileal MLW (μm) CIE-PLE
CIE-N
28.1
12.8
22.25
7.4
5
9
51
25.7
−.6514 <.001
Abbreviations: CIE-N, chronic inflammatory enteropathy with serum albumin concentration ≥2.5 g/dL; CIE-PLE, chronic inflammatory enteropathy with
protein-losing enteropathy (serum albumin <2.5 g/dL); MLW, mucosal lacteal width; IQR, interquartile range; VLW, villus lacteal width.
aSpearman correlation performed between lacteal variables and serum albumin.
*P-value as assessed by Spearman correlation.
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a blinded veterinary pathologist and veterinary pathologist-in-training to
score histopathologic lesions in the intestine using established guide-
lines, histopathologic evaluation of the intestine in dogs is known
to be subjective with significant interobserver variation.27,28 A final
limitation is that 2 dogs in the study did not have hypoadrenocorticism
definitively excluded before their enrollment in the study. Both dogs
had previously been treated with glucocorticoid treatment without clin-
ical improvement and hypoadrenocorticism therefore was considered
unlikely. Ideally, it would have been excluded definitively.
In conclusion, the use of LEC IHC allowed for identification of
both villus and apparent proprial mucosal IL in dogs with CIE. Several
abnormalities of the intestinal lymphatic vasculature were correlated
with lower serum albumin concentrations. The most notable finding
was the discovery of apparently distended proprial mucosal intestinal
lymphatics using LEC IHC, the most striking of which was seen in the
ileum of dogs with CIE and concurrent PLE. This apparent proprial
mucosal lymphangiectasia had not been recognized on routine H&E
evaluation of the lymphatics. Routine LD scoring using H&E did not
correlate with the changes in the proprial mucosal lymphatics, which
suggests that evaluation of the villus lacteals alone can underestimate
abnormalities to the lymphatic vasculature in dogs with CIE. This find-
ing should be assessed in a larger group of dogs with CIE with and
without concurrent hypoalbuminemia because the identification of
lymphangiectasia deeper in intestinal biopsy samples will impact the
therapeutic management of these cases.
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